Skip to main content
. 2015 May 4;6(26):23008–23014. doi: 10.18632/oncotarget.3984

Table 1. Patients characteristics.

patient number age phenotype (months) CNS Involvement hyperleucytosis Karyotype FISH Corticosensitivity Chemosensitivity
1 154 LAL T no yes abnormal tel-aml1 yes yes
2 82 LAL B no no abnormal negative yes yes
3 114 LAL B no no abnormal negative yes yes
4 52 LAL B no no abnormal negative no yes
5 35 LAL B no no abnormal negative yes yes
6 53 LAL B no no abnormal negative not evaluable yes
7 107 LAL B no no abnormal negative yes yes
8 45 LAL B no no normal negative no yes
9 190 LAL B no no abnormal tel-aml1 yes yes
10 65 LAL B no no normal negative not yes
11 91 LAL B no no abnormal negative ye yes
12 196 LAL B no no normal tel-aml1 yes yes
13 35 LAL B no no abnormal not done no yes
14 180 LAL T no no Failure negative yes yes
15 76 LAL B no no normal negative yes yes
16 61 LAL B no no abnormal negative yes yes
17 183 LAL B no no abnormal negative yes yes
18 91 LAL B no no normal negative yes yes
19 38 LAL B no yes abnormal negative yes yes
20 50 LAL B no yes normal negative yes yes
21 195 LAL B no no normal tel-aml1 yes yes
22 78 LAL B no no abnormal negative not evaluable yes
23 23 LAL B no no abnormal tel-aml1 not evaluable yes
24 72 LAL B yes no normal negative yes yes
25 39 LAL B no no normal negative not evaluable yes
26 35 LAL B no no abnormal tel-aml1 no yes
27 57 LAL B no no abnormal negative yes yes
28 55 LAL B no yes normal negative not evaluable yes
29 149 LAL T no no normal tel-aml1 yes yes
30 28 LAL B no no normal negative yes yes
31 51 LAL B no no abnormal negative yes yes
32 23 LAL B no no abnormal negative yes yes
33 97 LAL B no no abnormal tel-aml1 not evaluable yes
34 75 LAL B no no normal negative yes yes
35 30 LAL B no no abnormal mll+ no yes
36 184 LAL T no yes normal negative not evaluable yes
37 107 LAL B no no normal negative yes yes
38 52 LAL B no no normal tel-aml1 no yes
39 43 LAL B no yes abnormal negative yes yes
40 158 LAL B no no normal negative yes yes
41 47 LAL B no no normal negative yes yes
42 58 LAL B no no abnormal negative yes yes
43 147 LAL B no no abnormal negayive yes yes
44 157 LAL B no no normal negative yes yes
45 145 LAL B no no normal tel-aml1 not evaluable yes
46 57 LAL B no no abnormal negative not evaluable yes
47 62 LAL B no no abnormal negative not evaluable yes